Skip to main content
Premium Trial:

Request an Annual Quote

CeMines Establishes New Division for Genomics-Related Products and Services

NEW YORK, Aug. 4 (GenomeWeb News) -- Biotech company CeMines, of Evergreen, Colo., said last week that it has created a biosystems division that will focus on offering genomics-related research tools and services to the research and drug discovery market.


"We have the existing infrastructure necessary to enable CeMines to immediately accelerate the growth of sales from our existing product line of research tools, including antibodies, cDNA, and mRNA, and at the same time commence with our market introduction of a new family of products targeted at establishing CeMines as a premier brand in drug discovery and other markets," Roger Attick, president and CEO of CeMines said in an official statement.


Founded in 2000, the company has primarily uses gene regulation technology to help develop diagnostics and therapeutics for cancer. In June, the company expanded its diagnostics and therapeutics division and moved it to a new facility in La Jolla, Calif.


CeMines is attempting to commercialize its patent-pending Molecular FingerPrinting technology to aid in developing early-stage diagnostics and targeted therapeutics, the company said.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.